Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

Markerman thanks, like others the second one concerning the buildout suggests more of AML clinical study support than anything about Polystart,, yes?

The first, was July 16, with review assignment in October. Having read it carefully, I see the registration of a error free submission but, I did not read ' as intended for Polystart manufacturing, yes?

As with others, thank you for popping up with DD.. we're serious about that, because a few of us have been here for more than 6 years.. filled with RS and share issuance dilution and we are weary knowing our average share cost is really a ove $13 and we receive no y/e share awards

However, you brightened my day.. thanks.